Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma

Summary

RATIONALE: Vaccines made from a person's cancer cells may make the body build an immune response to kill tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of vaccine therapy in treating patients who have stage IV or recurrent melanoma.

Timeline

Start

2000-07

Primary completion

2011-04

Completion

2011-04

Publications

• Results Dillman RO, Schiltz PM, Selvan R, et al.: Patient-specific cancer vaccine of cultured autologous tumor cells and autologous dendritic cells. [Abstract] J Immunother 24 (5): S5, 2001.

Drugs

Indications